feature banner image

When your body turns on you, bad things can happen. Designed to guard against viruses, bacteria and foreign invaders, the immune system sometimes malfunctions, resulting in scleroderma, lupus and more than 80 other potentially crippling disorders. Scientists and clinicians at The University of Texas Health Science Center at Houston (UTHealth) have made critical research and patient care breakthroughs in autoimmune and autoinflammatory disease. They can share this expertise with reporters.

UTHealth specialists available for interview.

UTHealth research: low incidence of venous insufficiency in MS

Results of a study using several imaging methods showed that CCSVI (chronic cerebrospinal venous insufficiency) occurs at a low rate in both people with multiple sclerosis (MS) and non-MS volunteers, contrary to some previous studies. The research by an interdisciplinary team at The University of Texas Health Science Center at Houston (UTHealth) was published in a recent early online edition of the Annals of Neurology.

Continue reading »

Dr. John Reveille leads Pan American rheumatology consortium

John D. Reveille, M.D., director of the Division of Rheumatology and Clinical Immunogenetics at The University of Texas Health Science Center at Houston (UTHealth) Medical School, has been elected president of the Pan American League of Associations of Rheumatology (PANLAR), which represents the national rheumatology societies in 21 countries with a combined membership of 11,600 rheumatologists.

Continue reading »

UTHealth uses $1.9 million grant to study therapy for autoimmunity

A researcher at The University of Texas Health Science Center at Houston (UTHealth) is studying a novel cell therapy that could help avoid autoimmune problems after stem cell transplantation, as well as potentially treat other autoimmune diseases.

Continue reading »

More on this topic